Readiness to Change and Prospective Effects of Weight Management Programs in Pediatric Nonalcoholic Fatty Liver Disease

被引:3
|
作者
Slowik, Voytek [1 ]
Wasserkrug, Heather [1 ]
Fischer, Ryan T. [1 ]
Connelly, Mark [2 ]
Deacy, Amanda D. [1 ,2 ]
Hampl, Sarah [3 ,4 ]
Daniel, James F. [1 ]
机构
[1] Univ Missouri, Div Pediat Gastroenterol, Childrens Mercy Kansas City, Kansas City Sch Med, Kansas City, MO USA
[2] Univ Missouri, Div Dev & Behav Hlth, Childrens Mercy Kansas City, Kansas City Sch Med, Kansas City, MO USA
[3] Univ Missouri, Div Gen Acad Pediat, Childrens Mercy Kansas City, Kansas City Sch Med, Kansas City, MO USA
[4] Univ Missouri, Ctr Childrens Hlth Lifestyles & Nutr, Childrens Mercy Kansas City, Kansas City Sch Med, Kansas City, MO USA
来源
CTS-CLINICAL AND TRANSLATIONAL SCIENCE | 2021年 / 14卷 / 02期
关键词
OF-THE-LITERATURE; ADOLESCENT OVERWEIGHT; OBESITY; INTERVENTION; CHILDREN; OUTCOMES; MOTIVATION; ATTENDANCE; RISK;
D O I
10.1111/cts.12913
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is an increasing problem in pediatrics with limited treatment options. We prospectively assessed outcomes in patients managed in a hepatology clinic (HC) alone vs. those managed in combination with a multidisciplinary weight management program (MWMP). We describe each group's readiness to change at the time of NAFLD diagnosis. Patients diagnosed with NAFLD were given a modified Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES) at enrollment (T1) to assess readiness to change. They were then followed at 3-9 months (T2) and at 10-15 months (T3). Linear mixed models were used to evaluate changes in body mass index (BMI), BMI z-score, and transaminases over time and between the two groups. There were no significant treatment group main effects or treatment x time interactions for our primary end points for HC alone (n = 75) or with MWMP (n = 18). There was a significant main effect for time for BMI z-score, with BMI z-scores declining on average by 0.0568 (P = 0.004) from visit to visit. Low SOCRATES subscales scores in HC alone (n = 33) or with MWMP (n = 4) suggested a patient population with low recognition of disease and likelihood of taking steps for change. Patients with obesity and NAFLD had low scores on all three SOCRATES subscales. Despite this, both groups had improvement in BMI z-score without significant difference between the two treatment groups in other primary end points. Further study is needed to identify the most effective patient selection and treatment strategies for pediatric patients with NAFLD, including pharmacotherapy and surgery.
引用
收藏
页码:582 / 588
页数:7
相关论文
共 50 条
  • [41] Role of Exercise in Mitigating Pediatric Nonalcoholic Fatty Liver Disease
    Vittorio, Jennifer M.
    Lavine, Joel E.
    DIABETES CARE, 2020, 43 (02) : 280 - 282
  • [42] Vitamin E Supplementation in Pediatric Nonalcoholic Fatty Liver Disease
    Patusco, Rachael
    Zelig, Rena
    Parker, Anna
    TOPICS IN CLINICAL NUTRITION, 2018, 33 (01) : 50 - 68
  • [43] A Critical Appraisal of Advances in Pediatric Nonalcoholic Fatty Liver Disease
    Ovchinsky, Nadia
    Lavine, Joel E.
    SEMINARS IN LIVER DISEASE, 2012, 32 (04) : 317 - 324
  • [44] Management of nonalcoholic fatty liver disease in the Middle East
    Sanai, Faisal M.
    Abaalkhail, Faisal
    Hasan, Fuad
    Farooqi, Muhammad Hamed
    Al Nahdi, Nawal
    Younossi, Zobair M.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (25) : 3528 - 3541
  • [45] The Role of Statins in the Management of Nonalcoholic Fatty Liver Disease
    Doumas, Michael
    Imprialos, Konstantinos
    Dimakopoulou, Aikaterini
    Stavropoulos, Konstantinos
    Binas, Athanasios
    Athyros, Vasilios G.
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (38) : 4587 - 4592
  • [46] Current management of patients with nonalcoholic fatty liver disease
    Elsheikh, Elzafir
    Henry, Linda L.
    Younossi, Zobair M.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2013, 8 (06) : 549 - 558
  • [47] Medical Approach for Weight Loss in Nonalcoholic Fatty Liver Disease
    Do A.
    Ilagan-Ying Y.C.
    Mehal W.Z.
    Current Hepatology Reports, 2019, 18 (4) : 444 - 454
  • [48] Role of Docosahexaenoic Acid Treatment in Improving Liver Histology in Pediatric Nonalcoholic Fatty Liver Disease
    Nobili, Valerio
    Carpino, Guido
    Alisi, Anna
    De Vito, Rita
    Franchitto, Antonio
    Alpini, Gianfranco
    Onori, Paolo
    Gaudio, Eugenio
    PLOS ONE, 2014, 9 (02):
  • [49] The clinicopathologic spectrum and management of nonalcoholic fatty liver disease
    Contos, MJ
    Sanyal, TJ
    ADVANCES IN ANATOMIC PATHOLOGY, 2002, 9 (01) : 37 - 51
  • [50] Nonalcoholic Fatty Liver Disease in Children
    Mann, Jake P.
    Valenti, Luca
    Scorletti, Eleonora
    Byrne, Christopher D.
    Nobili, Valerio
    SEMINARS IN LIVER DISEASE, 2018, 38 (01) : 1 - 13